Loading...

LIMN LIMINATUS PHARMA INC Company Mergers 8-K Filing

LMNT

LMN

LIMINATUS PHARMA INC

(LIMN)

2026 8-K

Merger Announcement

Bylaw Amendment

Stock Offering Details

Settlement Agreement

Delisting Notice

Nasdaq Non-Compliance

Nasdaq Non-Compliance

Research Update

Investor Meetings

Non-Compliance Notification

Merger of Equals

Merger of Equals

External Links:

Liminatus Pharma, Inc. has entered into a Merger Agreement with InnocsAI LLC on May 17, 2026, to acquire 1.6 billion shares of its common stock at $0.20 each, in exchange for InnocsAI's oncology-focused assets.

AI Assistant

LIMINATUS PHARMA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.